Office for State, Tribal, Local and Territorial Support (OSTLTS), 75923-75924 [2013-29746]

Download as PDF Federal Register / Vol. 78, No. 240 / Friday, December 13, 2013 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–29745 Filed 12–12–13; 8:45 am] [FR Doc. 2013–29750 Filed 12–12–13; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review ehiers on DSK2VPTVN1PROD with NOTICES Prevention and the Agency for Toxic Substances and Disease Registry. Advisory Committee on Breast Cancer in Young Women (ACBCYW) The meeting announced below concerns Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monkeypox in Tshuapa District, Democratic Republic of the Congo, Funding Opportunity Announcement (FOA) CK14–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time And Date: 1:00 p.m.–3:00 p.m., February 18, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monkeypox in Tshuapa District, Democratic Republic of the Congo, FOA CK14–002’’. Contact Person For More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718– 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Mar<15>2010 13:32 Dec 12, 2013 Jkt 232001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 9:00 a.m.–3:00 p.m. EST, January 9, 2014. Place: The meeting will be held via Teleconference. Limited teleconference access is also available. Teleconference login information is as follows: For Public: TOLL–FREE PHONE #: 888–989–8135 Participant passcode: BREASTCANCER or 273278226237 For Public: Net Conference URL: https://www.my meetings.com/nc/join/ Conference number: PW3233834 Audience passcode: BREASTCANCER or Public can join the event directly at: https://www.mymeetings.com/nc/join. php?i=PW3233834&p=BREAST CANCER&t=c. There is also a toll free number for anyone outside of the USA: TOLL #: 1– 203–827–7034. Participant passcode: BREASTCANCER or 273278226237. Status: Open to the public, limited only by the net conference and audio phone lines available. Purpose: The committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 75923 dissemination of credible appropriate messages and resource materials. Matters To Be Discussed: The agenda will include discussions on the current and emerging topics related to breast cancer in young women. These may include risk communication and health education, as well as approaches to increase awareness of clinicians/ practitioners regarding topics such as breast cancer risk, breast health, symptoms, diagnosis, and treatment of breast cancer in young women. Agenda items are subject to change as priorities dictate. Online Registration Required: All ACBCYW Meeting participants must register for the meeting online at least 5 days in advance at http://www.cdc.gov/ cancer/breast/what_cdc_is_doing/ meetings.htm. Please complete all the required fields before submitting your registration and submit no later than January 5, 2014. Contact Person For More Information: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway NE., Mailstop K52, Atlanta, Georgia 30341, Telephone (770) 488–4518, Fax (770) 488–4760 Email: acbcyw@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–29749 Filed 12–12–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Office for State, Tribal, Local and Territorial Support (OSTLTS) In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of November 5, 2009, and September 23, 2004, Consultation and Coordination with Indian Tribal Governments, CDC/Agency for Toxic Substances and Disease Registry (ATSDR), announces the following meeting and Tribal Consultation Session: E:\FR\FM\13DEN1.SGM 13DEN1 ehiers on DSK2VPTVN1PROD with NOTICES 75924 Federal Register / Vol. 78, No. 240 / Friday, December 13, 2013 / Notices Name: Tribal Advisory Committee (TAC) Meeting and 10th Biannual Tribal Consultation Session Times and Dates: 8:00 a.m.–5:00 p.m., February 18, 2014 (TAC Meeting); 8:00 a.m.– 5:00 p.m., February 19, 2014 (10th Biannual Tribal Consultation Session). Place: The TAC Meeting and Tribal Consultation Session will be held at CDC Headquarters, 1600 Clifton Road NE., Global Communications Center, Auditorium B3, Atlanta, Georgia 30333. Status: The meetings are being hosted by CDC/ATSDR and are open to the public. Purpose: In 2011–2012, CDC began revising its existing Tribal Consultation Policy (issued in 2005) with the primary purpose of providing guidance across the agency to work effectively with American Indian/Alaska Native (AI/AN) tribes, communities, and organizations to enhance AI/AN access to CDC resources and programs. Within the CDC Consultation Policy, it is stated that CDC will conduct government-to-government consultation with elected tribal officials or their authorized representatives before taking actions and/or making decisions that affect them. Consultation is an enhanced form of communication that emphasizes trust, respect, and shared responsibility. It is an open and free exchange of information and opinion among parties that leads to mutual understanding and comprehension. CDC believes that consultation is integral to a deliberative process that results in effective collaboration and informed decision making with the ultimate goal of reaching consensus on issues. Although formal responsibility for the agency’s overall government-togovernment consultation activities rests within the CDC Office of the Director (OD), other CDC Center, Institute, and Office (CIO) leadership shall actively participate in TAC meetings and HHS-sponsored regional and national tribal consultation sessions as frequently as possible. Matters To Be Discussed: The TAC and CDC leaders will discuss the following public health issue topics identified by tribal leaders: Native specimens, behavioral risk factors, and disease-specific topics; however, discussion is not limited to these topics. During the 10th Biannual Tribal Consultation Session, tribes and CDC leaders will engage in a listening session with CDC’s director and roundtable discussions with CDC senior leadership, and tribes will have an opportunity to present testimony on tribal health issues. Tribal Leaders are encouraged to submit written testimony by 12:00 a.m., EST on January 24, 2014, to April R. Taylor, Public Health Analyst for the Tribal Support Unit, or CAPT Craig Wilkins, Acting Director for the Tribal Support Unit, CDC/OSTLTS, via mail to 4770 Buford Highway NE., MS E–70, Atlanta, Georgia 30341 or email to tribalsupport@cdc.gov. Depending on the time available, it may be necessary to limit the time of each presenter. The agenda is subject to change as priorities dictate. Information about the TAC, CDC’s Tribal Consultation Policy, and previous meetings may be referenced on the following web link: http://www.cdc.gov/tribal. VerDate Mar<15>2010 13:32 Dec 12, 2013 Jkt 232001 Contact Person For More Information: April R. Taylor, Public Health Analyst, CDC/ OSTLTS, via mail to 4770 Buford Highway NE., MS E–70, Atlanta, Georgia 30341 or email to ARTaylor@cdc.gov. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–29746 Filed 12–12–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Request for Nominations of Candidates To Serve on the Mine Safety and Health Research Advisory Committee (MSHRAC), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS) The CDC is soliciting nominations for possible membership on the Mine Safety and Health Research Advisory Committee (MSHRAC), National Institute for Occupational Safety and Health (NIOSH). CDC provides subject-matter expertise and assistance for domestic and global surveillance, laboratory, occupational health and epidemiology functions, and health threats including anthrax, smallpox, influenza and other infectious diseases, food-borne illness, and radiation, among others. The MSHRAC consists of 13 experts in fields related to mining safety and health. The members are selected by the Secretary, HHS. The committee advises the NIOSH Director on mining safety and health research and prevention programs. The committee also provides advice on standards of scientific excellence, current needs in the field of mining safety and health, and the applicability and dissemination of research findings. This advice may take the form of reports or verbal communications to the NIOSH Director during MSHRAC meetings. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishment of the committee’s mission. PO 00000 Frm 00015 Fmt 4703 Sfmt 9990 Nominees will be selected based on expertise in the field of mining safety and health, such as mining engineering, industrial hygiene, occupational safety and health engineering, chemistry, safety and health education, ergonomics, epidemiology, statistics, and psychology. Federal employees will not be considered for membership. Members may be invited to serve for terms of up to four years. The U.S. Department of Health and Human Services policy stipulates that committee membership shall be balanced in terms of professional training and background, points of view represented, and the committee’s function. In addition to a broad range of expertise, consideration is given to a broad representation of geographic areas within the U.S., with diverse representation of both genders, ethnic and racial minorities, and persons with disabilities. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: • Current curriculum vitae, including complete contact information (name, affiliation, mailing address, telephone number, email address) • A letter of recommendation stating the qualifications of the candidate. Nomination materials must be postmarked by January 31, 2014, and sent to: Jeffery L. Kohler, Ph.D., Executive Secretary, MSHRAC, NIOSH, CDC, 626 Cochrans Mill Road, P.O. Box 18070, Pittsburgh, Pennsylvania 15236, telephone (412) 386–5301. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–29747 Filed 12–12–13; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\13DEN1.SGM 13DEN1

Agencies

[Federal Register Volume 78, Number 240 (Friday, December 13, 2013)]
[Notices]
[Pages 75923-75924]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-29746]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


Office for State, Tribal, Local and Territorial Support (OSTLTS)

    In accordance with Presidential Executive Order No. 13175, November 
6, 2000, and the Presidential Memorandum of November 5, 2009, and 
September 23, 2004, Consultation and Coordination with Indian Tribal 
Governments, CDC/Agency for Toxic Substances and Disease Registry 
(ATSDR), announces the following meeting and Tribal Consultation 
Session:


[[Page 75924]]


    Name: Tribal Advisory Committee (TAC) Meeting and 10th Biannual 
Tribal Consultation Session
    Times and Dates: 8:00 a.m.-5:00 p.m., February 18, 2014 (TAC 
Meeting); 8:00 a.m.-5:00 p.m., February 19, 2014 (10th Biannual 
Tribal Consultation Session).
    Place: The TAC Meeting and Tribal Consultation Session will be 
held at CDC Headquarters, 1600 Clifton Road NE., Global 
Communications Center, Auditorium B3, Atlanta, Georgia 30333.
    Status: The meetings are being hosted by CDC/ATSDR and are open 
to the public.
    Purpose: In 2011-2012, CDC began revising its existing Tribal 
Consultation Policy (issued in 2005) with the primary purpose of 
providing guidance across the agency to work effectively with 
American Indian/Alaska Native (AI/AN) tribes, communities, and 
organizations to enhance AI/AN access to CDC resources and programs. 
Within the CDC Consultation Policy, it is stated that CDC will 
conduct government-to-government consultation with elected tribal 
officials or their authorized representatives before taking actions 
and/or making decisions that affect them. Consultation is an 
enhanced form of communication that emphasizes trust, respect, and 
shared responsibility. It is an open and free exchange of 
information and opinion among parties that leads to mutual 
understanding and comprehension. CDC believes that consultation is 
integral to a deliberative process that results in effective 
collaboration and informed decision making with the ultimate goal of 
reaching consensus on issues. Although formal responsibility for the 
agency's overall government-to-government consultation activities 
rests within the CDC Office of the Director (OD), other CDC Center, 
Institute, and Office (CIO) leadership shall actively participate in 
TAC meetings and HHS-sponsored regional and national tribal 
consultation sessions as frequently as possible.
    Matters To Be Discussed: The TAC and CDC leaders will discuss 
the following public health issue topics identified by tribal 
leaders: Native specimens, behavioral risk factors, and disease-
specific topics; however, discussion is not limited to these topics.
    During the 10th Biannual Tribal Consultation Session, tribes and 
CDC leaders will engage in a listening session with CDC's director 
and roundtable discussions with CDC senior leadership, and tribes 
will have an opportunity to present testimony on tribal health 
issues.
    Tribal Leaders are encouraged to submit written testimony by 
12:00 a.m., EST on January 24, 2014, to April R. Taylor, Public 
Health Analyst for the Tribal Support Unit, or CAPT Craig Wilkins, 
Acting Director for the Tribal Support Unit, CDC/OSTLTS, via mail to 
4770 Buford Highway NE., MS E-70, Atlanta, Georgia 30341 or email to 
tribalsupport@cdc.gov. Depending on the time available, it may be 
necessary to limit the time of each presenter.
    The agenda is subject to change as priorities dictate.
    Information about the TAC, CDC's Tribal Consultation Policy, and 
previous meetings may be referenced on the following web link: 
http://www.cdc.gov/tribal.
    Contact Person For More Information: April R. Taylor, Public 
Health Analyst, CDC/OSTLTS, via mail to 4770 Buford Highway NE., MS 
E-70, Atlanta, Georgia 30341 or email to ARTaylor@cdc.gov.

    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention, 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-29746 Filed 12-12-13; 8:45 am]
BILLING CODE 4163-18-P